The India in vitro diagnostics market was valued at USD 2.80 Billion in 2025, driven by the rising prevalence of chronic diseases and government initiatives across the region. The market is anticipated to grow at a CAGR of 6.10% during the forecast period of 2026-2035, with the values likely to reach USD 5.06 Billion by 2035. The market is driven by increasing technological advancements like molecular diagnostics, expansion in healthcare infrastructure, and personalized medicine adoption.
Base Year
Historical Period
Forecast Period
In March 2024, India’s Agilus Diagnostics partnered with SEAS International to launch a state-of-the-art referral laboratory in Oman, enhancing its Middle East presence and driving demand in the expanding in-vitro diagnostics market.
Advancements in AI, molecular diagnostics, and point-of-care testing are revolutionizing India in vitro diagnostics market, enhancing diagnostic accuracy, accessibility, and efficiency, particularly in rural and underserved regions.
Several IVD companies in India are focusing on product innovation, strategic partnerships, and government collaborations to strengthen their market presence and cater to the growing demand for diagnostic solutions.
Compound Annual Growth Rate
6.1%
Value in USD Billion
2026-2035
*this image is indicative*
In vitro diagnostics (IVD) encompass medical tests conducted on biological samples such as blood, urine, or tissues to detect diseases, monitor health conditions, and support clinical decision-making. These diagnostics play a vital role in preventive healthcare, disease management, and personalized medicine. The market was valued at USD 2.80 Billion in 2025 and is experiencing significant growth, driven by rising healthcare awareness, increased prevalence of chronic diseases, and advancements in diagnostic technologies. Expanding healthcare infrastructure and greater emphasis on early and accurate diagnosis further support market expansion.
Rising Burden of Non-Communicable Diseases to Drive Growth in the Market
The escalating prevalence of chronic and non-communicable diseases (NCDs) in India is a key driver of growth in the in vitro diagnostics market. According to the Ministry of Science and Technology, Government of India, NCDs are responsible for 53% of all deaths and contribute to 44% of disability-adjusted life years lost across the country. This substantial disease burden necessitates early and accurate diagnosis, leading to increased demand for advanced in vitro diagnostic technologies. Consequently, the rising incidence of NCDs is expected to significantly propel the expansion of the market in the coming years.
The market is experiencing several key trends, including in vitro diagnostics companies expanding their direct operations and local manufacturing in India, alongside the growth of disease-specific in vitro diagnostic solutions:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product & Services
Market Breakup by Technology
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Reagents and Kits Segment is Likely to Lead the Market
The market encompasses three primary segments based on products and services, including reagents and kits, instruments, and software and services. The reagents and kits segment is expected to hold a significant share in the market, driven by its critical role in diagnostic testing. For instance, in May 2022, Cipla Limited introduced the ‘RT-Direct’ multiplex COVID-19 RT-PCR test kit, validated by the Indian Council of Medical Research, exemplifying the increased adoption of advanced diagnostic kits. This growth is supported by rising incidences of chronic and infectious diseases and advancements in point-of-care testing technologies.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Founded in 1888 and headquartered in Abbott Park, Illinois, Abbott is a leading global healthcare company. In February 2025, Abbott received FDA clearance for its self-collected Simpli-COLLECT molecular test for sexually transmitted infections. This innovation strengthens Abbott’s role in in vitro diagnostics market by enhancing accessible, accurate molecular testing solutions.
Qiagen continues to drive innovation in molecular diagnostics with plans to launch three automated sample preparation instruments by 2026, including the high-throughput QIAsymphony Connect and QIAsprint Connect systems. Founded in 1984, the company leverages these technologies to enhance laboratory efficiency and precision, solidifying its significant role in the expanding in vitro diagnostics market.
Quidel Corporation, headquartered in San Diego, California, has a significant presence in the market. The company offers MicroVue diagnostic products, including ELISA kits for assessing bone health and complement system activity. These specialized immunoassays help monitor bone turnover and immune function, supporting early diagnosis and clinical decision-making across diagnostic laboratories in India.
Danaher Corporation is headquartered in Washington, DC, and was established in 1984. Through its subsidiary, Beckman Coulter, the company specializes in innovative in vitro diagnostic systems that support disease detection, treatment decisions, and patient monitoring. The company’s advanced diagnostic technologies contribute significantly to addressing the rising burden of chronic diseases and improving healthcare outcomes.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include F. Hoffmann-La Roche Ltd., Transasia Bio-Medicals Ltd., Bio-Rad Laboratories, Inc., bioMérieux SA, Thermo Fisher Scientific Inc., and Sysmex Corporation.
Upto 15% Off
USD
$3099 $2789
$1999 $1799
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product & Services |
|
| Breakup by Technology |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share